The control of blood glucose levels in diabetes involving devices are critically reviewed, and the role of blood-contacting biomaterial components analyzed. These include mechanical insulin-delivery systems of the closed-loop type that require an electronic glucose sensor and feedback, and open-loop systems that deliver insulin without a sensor and feedback. Whole pancreatic and islet transplantations, islet encapsulation, and the potential role of polymeric sustained drug delivery systems are discussed. The medical and social impacts of diabetes mellitus are of prime public health concern and of even greater magnitude than those of heart disease in the United States. While future advances in device design, miniaturization, and biometrials technology will significantly add to the arsenal of therapeutic alternatives, devices capable of controlling blood glucose levels ought to be viewed as mere interim phases rather than as final goals of the problem.
StoutR.W.: Diabetes and atherosclerosis — the role of insulin.Diabetologia16: 141, 1979.
2.
KeeneH., JarrettR.J.: Microangiopathy — its prevalence in asymptomatic diabetes.Adv. Metab. Disord. (Supple.)2: 3, 1973.
3.
OstranderL.D., FrancisT., HaynerN.S., KjelsbergM.O., EpsteinF.H.: The relationship of cardiovascular disease to hyperglycemia.Ann. Int. Med.62: 1188, 1965.
4.
PellS., D'AlonzoC.A.: Factors associated with long-term survival of diabetes.JAMA214: 1833, 1970.
5.
EpsteinF.H., OstranderL.D., JohnsonB.J., PayneM.W., HaynerN.S., KellerJ.B., FrancisT.: Epidemiological studies of cardiovascular disease in a total community — Tecumseh, Mich.Ann. Int. Med.62: 1170, 1965.
6.
American Diabetes Association: Policy Statement — Blood glucose control in diabetes.Diabetes25: 237, 1976.
7.
LefebvreP.J., LuyckxA.S.: Glucagon and diabetes: A reappraisal.Diabetologia16: 347, 1979.
8.
MichaelsA.S.: Application of the theory of molecular transport in polymers to the design of controlled drug-delivery systems.Polymer Preprints20: 332, 1979.
9.
MaloneJ.L.: Newer aspects of diabetes.Adv. Pediatrics24: 1, 1977.
10.
MacLarenK.: Viral and immunological bases of beta cell failure in insulin-dependent diabetes.Am. J. Dis. Child, 131: 1149, 1977.
11.
YoonJ.-W., AustinM., OnoderaT., NotkinsA.L.: Virus-induced diabetes mellitus.Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. New Engl. J. Med.300: 1173, 1979.
12.
SantiagoJ.V., ClemensA.H., ClarkeW.L., KipnisD.M.: Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects.Diabetes28: 71, 1979.
13.
PfeifferE.F., ThumC., ClemensA.H.: The artificial beta cell — a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).Horm. Metab. Res.487: 339, 1974.
14.
ElliottJ.: Development of an artificial pancreas: The race is on.JAMA241: 223, 1979.
15.
GoriyaJ., BahoricA., MarlissE.B., ZinmanB., AlbisserA.M.: Glycemic regulation using a programmed insulin delivery device III.Long-term studies on diabetic dogs. Diabetes28: 558, 1979.
16.
GottV.L., RamosM.D., NajjarF.B., AllenJ.L., BeckerK.E.: The in vivo screening of potential thromboresistant materials, in Proceedings of the Artificial Heart Program Conference, June 9–13, 1969, U.S. Dept. HEW/NIH, U.S. Gov. Printing Office, Washington, D.C.
17.
BruckS.D.: Blood Compatible Synthetic Polymers — An Introduction.C.C. Thomas Publisher, Springfield, Illinois, 1974.
18.
BruckS.D.: Properties of Biomaterials in the Physiological Environment.CRC Press, Boca Raton, Florida, in press 1980.
19.
ChangK.W., AisenbergS., SoeldnerJ.S., HiebertJ.M.: Validation and bioengineering aspects of an implantable glucose sensor.Trans. Am. Soc. Artif. Int. Organs19: 352, 1973.
20.
BlackshearP.J., RohdeT.D., GrottingJ.C., DormanF.D., PerkinsP.R., VarcoR.L., BuchwaldH.: Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device.Diabetes28: 634, 1979.
ChickW.L., PernaJ.L., LaurisV., LowD., GallettiP.M., PanolG., WhittemoreA.D., LikeA.A., ColtonC.K., LysaghtM.J.: Artificial pancreas using living beta cells: Effect on glucose homeostasis in diabetic rats.Science197: 780, 1977.
24.
SunA.M., ParisiusW., HealyG.M., VacekI., MacmorineH.G.: The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas).Diabetes26: 1136, 1977.
25.
deShazoR.D.: Insulin allergy and insulin resistance.Postgrad. Med.63: 85, 1978.
26.
LilleheiR.C., RuixJ.O., AquinoC., GoetzF.: Transplantation of the pancreas.Acta Endocr. (Suppl.)205: 303, 1976.
27.
NajarianJ.S.: Islet cell transplantation in treatment of diabetes.Hosp. Practice, October, 1977, p. 63.
BrooksJ.R.: in Endocrine Tissue Transplantation.KugelmanI.N., Ed., C.C. Thomas Publisher, Springfield, Illinois, 1962.
30.
LacyP.E., KostianovskyM.: Method for the isolation of intact islets of Langerhans from the rat pancreas.Diabetes16: 35, 1967.
31.
MoskalewskiS.: Isolation and culture of the islets of Langerhans of the guinea pig.Gen. Comp. Endocrin.5: 342, 1965.
32.
LindallA.W., SteffesM., SorensonR.: Immunoassayable content of subcellular fractions of rat islets.Endocrinol.85: 218, 1969.
33.
BallingerW.F., LacyP.E.: Transplantation of intact pancreatic islets of rats.Surg.72: 175, 1972.
34.
MaurerC.A.: The therapy of diabetes.American Scientist67: 422, 1979.
35.
DavisB.K.: Diffusion in polymer gel implants.Proc. Nat. Acad. Sci. USA71: 3120, 1974.
36.
DavisB.K.: Control of diabetes with Polyacrylamide implants containing insulin.Experimentia28: 348, 1972.
37.
GimbroneM.A., CotranR.S., LeapmanS.B., FolkmanJ.: Tumor growth and neovascularization: An experimental model using the rabbit cornea.J. Natl. Cancer Inst.52: 413, 1974.
38.
LangerR., FolkmanJ.: Polymers for the sustained release of proteins and other macromolecules.Nature263: 797, 1976.
39.
RhineW.D., HsiehD.S.T., LangerR.S.: Kinetics of polymeric delivery systems for proteins and other macromolecules.Polymer Preprints20(No. 1): 596, 1979.
